Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A laboratory test (using tissue or fluid samples) has confirmed a diagnosis of non-small cell lung cancer.
- Age is between 18 and 75 years old.
- The person is willing to take part in the study and sign a consent form agreeing to participate.
- The cancer has not yet been treated.
- The cancer does not have certain gene changes (called "driver gene negativity") that can drive cancer growth.
- Based on a standard lung cancer staging system (AJCC 8th edition), the cancer is classified as stage IIIB or IIIC and is considered potentially removable by surgery.
- The person's general health and ability to carry out daily activities is rated at 0 or 1 on a standard scale (ECOG score), meaning they are fully active or have only minor limitations.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable to understand what the trial involves, are unable to cooperate with the study, or who are not willing to sign the consent form.
- People who have small cell lung cancer (a different type of lung cancer).
- People whose cancer does have certain gene changes (called "driver gene positivity") that drive cancer growth.
- People whose cancer has grown directly into nearby structures such as the food pipe, heart, main blood vessel (aorta), diaphragm, windpipe, or airway branching point, or whose cancer is considered unable to be surgically removed even after initial treatment.
- People who have had a transplant of a solid organ (such as a kidney or liver) or a blood system transplant (such as a bone marrow transplant).
- People who have previously been treated with certain types of immunotherapy drugs that work on specific immune system pathways (CTLA-4, PD-1, or PD-L1 inhibitors).
- People who have a condition where the lung tissue becomes scarred or inflamed (interstitial lung disease).
- People who currently have an active or ongoing infection, whether acute (short-term) or chronic (long-term).
- Women who are pregnant or currently breastfeeding.
- People who are already participating in another clinical drug trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predicting Progression Free Survival; Predicting pathologic complete response; Predicting Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.